Three IPO Conference Alumni Selected Among Global Top 250 at Entrepreneurship World Cup Finals

Singapore / Asia 22 Jan 2026 — Boustead APEX, Inc. (BAI) proudly announces that three high-growth companies, originally shortlisted through the IPO Conference (IPOC) judging process, have achieved global recognition at the Entrepreneurship World Cup (EWC), emerging as Indo-Pacific Winners and Global Top 250 finalists.

These companies were first identified and shortlisted by the IPO Conference panel of judges as being suited for cornerstone investment and having strong potential for a future U.S. public listing, following rigorous evaluation by leading capital markets practitioners including Raffles Capital, founded by Dr Charlie In, and Boustead & Company, through Boustead APEX.

EWC Indo-Pacific Winners & Global Top 250 Alumni from IPO Conference

l Easybook (Growth Category) — IPOC Singapore

l Fuzhu Mingsheng Pharmaceuticals Co., Ltd. (Early Category) — IPOC China

l MedPHA (Growth Category) — IPOC Macau

*Photo: IPO Conference Singapore group photo featuring representatives from Easybook and others.

*Photo: IPO Conference Macau group photo featuring representatives from MedPHA.

Originally shortlisted during IPO Conference, these companies went on to outperform hundreds of regional contenders, securing their place among the Top 250 companies globally at the Entrepreneurship World Cup Finals—underscoring IPOC’s role as a proven launchpad for globally investable, IPO-ready enterprises.

Industry Leaders’ Perspectives

Dr. Marcuz Tan, CEO of Boustead APEX, Inc., said:

“The success of these companies at the Entrepreneurship World Cup reinforces what we look for at IPO Conference—scalable business models, credible leadership, and the discipline required for U.S. public markets. Being shortlisted through IPOC is not about promotion; it is about readiness. These outcomes demonstrate that the IPO Conference process consistently identifies companies capable of competing on a global stage.”

Dr. Charlie In, Founder of Raffles Capital and Cornerstone Investor, added:

“Our role as a cornerstone investor is to identify companies early that have both growth potential and the governance mindset required for public markets. The fact that Easybook, Fuzhu Mingsheng Pharmaceuticals, and MedPHA progressed from IPO Conference to the EWC Global Top 250 confirms the strength of IPOC as a high-quality filter for investable, IPO-ready companies.”

From IPO Conference to Global Recognition

The IPO Conference judging framework focuses on:

l U.S. public-market readiness

l Scalability and governance standards

l Institutional and cornerstone investor alignment

Being shortlisted by IPOC and subsequently validated by EWC affirms the quality, credibility, and global competitiveness of these companies.

IPO Conference Season 2 launches Singapore in Feb 2026, and expanded conference to include Investor Forum.

About Boustead APEX, Inc. (BAI):

Boustead APEX, Inc. (BAI) is a leading IPO advisory firm specializing in guiding Asian companies through the complexities of public listings on the NYSE and NASDAQ exchanges. Backed by US-based Boustead & Company Limited and Singapore-based Raffles Capital, BAI provides comprehensive support and access to global capital markets.

For more information, please visit www.bousteadapex.com.

About Boustead & Company Limited

Boustead & Company Limited is a diversified financial services firm headquartered in Irvine, CA, with offices in Austin, Boca Raton, San Francisco, New York, Beijing, London, Mauritius, Monaco, Singapore, and Zug. Boustead & Company Limited and its affiliates offer mergers & acquisitions, capital markets, project finance, pre-transaction advisory, financial restructuring, sales & trading, crowdfunding, and business valuation services to emerging growth and middle-market companies.

Raffles Capital Limited

Raffles Capital Ltd “RC” (incorporated in Wyoming, United States) acts as venture-accelerator for promising firms that are ready and qualifies for a public listing on a North America bourse within 18-24 months of vesting. RC works with companies that can deliver social impact bringing prosperity and progress to the people and planet. These firms’ purpose must be in alignment with the UN 17 Sustainable Development Goals.

Media Contact

Asia Investor Relations Pte Ltd

Faralynn Wongfaralynn@asiainvestorrelations.com